1
|
Podolski-Renić A, Čipak Gašparović A, Valente A, López Ó, Bormio Nunes JH, Kowol CR, Heffeter P, Filipović NR. Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer. Eur J Med Chem 2024; 270:116363. [PMID: 38593587 DOI: 10.1016/j.ejmech.2024.116363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2024] [Revised: 03/15/2024] [Accepted: 03/25/2024] [Indexed: 04/11/2024]
Abstract
Overcoming multidrug resistance (MDR) is one of the major challenges in cancer therapy. In this respect, Schiff base-related compounds (bearing a R1R2CNR3 bond) gained high interest during the past decades. Schiff bases are considered privileged ligands for various reasons, including the easiness of their preparation and the possibility to form complexes with almost all transition metal ions. Schiff bases and their metal complexes exhibit many types of biological activities and are used for the treatment and diagnosis of various diseases. Until now, 13 Schiff bases have been investigated in clinical trials for cancer treatment and hypoxia imaging. This review represents the first collection of Schiff bases and their complexes which demonstrated MDR-reversal activity. The areas of drug resistance covered in this article involve: 1) Modulation of ABC transporter function, 2) Targeting lysosomal ABCB1 overexpression, 3) Circumvention of ABC transporter-mediated drug efflux by alternative routes of drug uptake, 4) Selective activity against MDR cancer models (collateral sensitivity), 5) Targeting GSH-detoxifying systems, 6) Overcoming apoptosis resistance by inducing necrosis and paraptosis, 7) Reactivation of mutated p53, 8) Restoration of sensitivity to DNA-damaging anticancer therapy, and 9) Overcoming drug resistance through modulation of the immune system. Through this approach, we would like to draw attention to Schiff bases and their metal complexes representing highly interesting anticancer drug candidates with the ability to overcome MDR.
Collapse
Affiliation(s)
- Ana Podolski-Renić
- Department of Neurobiology, Institute for Biological Research "Siniša Stanković" - National Institute of Republic of Serbia, University of Belgrade, Serbia
| | | | - Andreia Valente
- Centro de Química Estrutural and Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, Lisboa, Portugal
| | - Óscar López
- Departamento de Química Organica, Facultad de Química, Universidad de Sevilla, Sevilla, Spain
| | - Julia H Bormio Nunes
- Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria; Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
| | - Christian R Kowol
- Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria
| | - Petra Heffeter
- Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
| | - Nenad R Filipović
- Department of Chemistry and Biochemistry, University of Belgrade, Belgrade, Serbia.
| |
Collapse
|
2
|
Presenjit, Chaturvedi S, Singh A, Gautam D, Singh K, Mishra AK. An Insight into the Effect of Schiff Base and their d and f Block Metal Complexes on Various Cancer Cell Lines as Anticancer Agents: A Review. Anticancer Agents Med Chem 2024; 24:488-503. [PMID: 38279753 DOI: 10.2174/0118715206280314231201111358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2023] [Revised: 10/24/2023] [Accepted: 11/02/2023] [Indexed: 01/28/2024]
Abstract
Over the last few decades, an alarming rise in the percentage of individuals with cancer and those with multi-resistant illnesses has forced researchers to explore possibilities for novel therapeutic approaches. Numerous medications currently exist to treat various disorders, and the development of small molecules as anticancer agents has considerable potential. However, the widespread prevalence of resistance to multiple drugs in cancer indicates that it is necessary to discover novel and promising compounds with ideal characteristics that could overcome the multidrug resistance issue. The utilisation of metallo-drugs has served as a productive anticancer chemotherapeutic method, and this approach may be implemented for combating multi-resistant tumours more successfully. Schiff bases have been receiving a lot of attention as a group of compounds due to their adaptable metal chelating abilities, innate biologic properties, and versatility to tweak the structure to optimise it for a specific biological purpose. The biological relevance of Schiff base and related complexes, notably their anticancer effects, has increased in their popularity as bio-inorganic chemistry has progressed. As a result of learning about Schiff bases antitumor efficacy against multiple cancer cell lines and their complexes, researchers are motivated to develop novel, side-effect-free anticancer treatments. According to study reports from the past ten years, we are still seeking a powerful anticancer contender. This study highlights the potential of Schiff bases, a broad class of chemical molecules, as potent anticancer agents. In combination with other anticancer strategies, they enhance the efficacy of treatment by elevating the cytotoxicity of chemotherapy, surmounting drug resistance, and promoting targeted therapy. Schiff bases also cause cancer cell DNA repair, improve immunotherapy, prevent angiogenesis, cause apoptosis, and lessen the side effects of chemotherapy. The present review explores the development of potential Schiff base and their d and f block metal complexes as anticancer agents against various cancer cell lines.
Collapse
Affiliation(s)
- Presenjit
- Radiological Nuclear and Imaging Sciences, Institute of Nuclear Medicine & Allied Sciences, DRDO, Timarpur, 110054, Delhi, India
- Department of Chemistry, Babasaheb Bhimrao Ambedkar University, 226025, Lucknow, India
| | - Shubhra Chaturvedi
- Radiological Nuclear and Imaging Sciences, Institute of Nuclear Medicine & Allied Sciences, DRDO, Timarpur, 110054, Delhi, India
| | - Akanksha Singh
- Department of Zoology, Swami Shraddhanand College, University of Delhi, 110007, India
| | - Divya Gautam
- Radiological Nuclear and Imaging Sciences, Institute of Nuclear Medicine & Allied Sciences, DRDO, Timarpur, 110054, Delhi, India
- Centre of Nanotechnology, Indian Institute of Technology, Roorkee, 247667, Uttarakhand, India
| | - Kaman Singh
- Department of Chemistry, Babasaheb Bhimrao Ambedkar University, 226025, Lucknow, India
| | - Anil Kumar Mishra
- Radiological Nuclear and Imaging Sciences, Institute of Nuclear Medicine & Allied Sciences, DRDO, Timarpur, 110054, Delhi, India
| |
Collapse
|
3
|
Patyal M, Kaur K, Bala N, Gupta N, Malik AK. Innovative lanthanide complexes: Shaping the future of cancer/ tumor chemotherapy. J Trace Elem Med Biol 2023; 80:127277. [PMID: 37572546 DOI: 10.1016/j.jtemb.2023.127277] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Revised: 07/26/2023] [Accepted: 07/29/2023] [Indexed: 08/14/2023]
Abstract
Developing new therapeutic and diagnostic metals and metal complexes is a stunning example of how inorganic chemistry is rapidly becoming an essential part of modern medicine. More study of bio-coordination chemistry is needed to improve the design of compounds with fewer harmful side effects. Metal-containing drugs are widely utilized in the treatment of cancer. Platinum complexes are effective against some cancers, but new coordination compounds are being created with improved pharmacological properties and a broader spectrum of anticancer action. The coordination complexes of the 15 lanthanides or rare earth elements in the periodic table are crucial for diagnosing and treating cancer. Understanding and treating cancer requires the detection of binding lanthanide (III) ions or complexes to DNA and breaking DNA by these complexes. Current advances in lanthanide-based coordination complexes as anticancer treatments over the past five years are discussed in this study.
Collapse
Affiliation(s)
- Meenakshi Patyal
- Department of Chemistry, Punjabi University, Patiala, Punjab, India
| | - Kirandeep Kaur
- Department of Chemistry, Punjabi University, Patiala, Punjab, India
| | - Neeraj Bala
- Department of Chemistry, Patel Memorial National College, Punjab, India
| | - Nidhi Gupta
- Department of Chemistry, Punjabi University, Patiala, Punjab, India.
| | | |
Collapse
|
4
|
Majid SA, Mir JM, Jan G, Shalla AH. Schiff base complexes, cancer cell lines, and anticancer evaluation: a review. J COORD CHEM 2022. [DOI: 10.1080/00958972.2022.2131402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
| | | | - Gowhar Jan
- Department of Chemistry, IUST, Awantipora Pulwama, India
| | | |
Collapse
|
5
|
Gamov GA, Zavalishin MN. La3+, Ce3+, Eu3+, and Gd3+ Complex Formation with Hydrazones Derived from Pyridoxal 5'-Phosphate in a Neutral Tris–HCl Buffer. RUSS J INORG CHEM+ 2021. [DOI: 10.1134/s0036023621100053] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
6
|
Chen FF, Wang SH, Tang XY, Li JQ, Chi YX, Jin J. Syntheses, structures and luminescent properties of a series of Ln(III) coordination polymers. J COORD CHEM 2021. [DOI: 10.1080/00958972.2021.1885029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- Fei-Fei Chen
- School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, 116029, PR China
| | - Shi-He Wang
- School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, 116029, PR China
| | - Xiao-Yun Tang
- School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, 116029, PR China
| | - Jia-Qi Li
- School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, 116029, PR China
| | - Yu-Xian Chi
- School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, 116029, PR China
| | - Jing Jin
- School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, 116029, PR China
| |
Collapse
|
7
|
Abouzayed FI, Emam SM, Abouel-Enein SA. Synthesis, characterization and biological activity of nano-sized Co(II), Ni(II), Cu(II), Pd(II) and Ru(III) complexes of tetradentate hydrazone ligand. J Mol Struct 2020. [DOI: 10.1016/j.molstruc.2020.128314] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
8
|
Tadele KT, Tsega TW. Schiff Bases and their Metal Complexes as Potential Anticancer Candidates: A Review of Recent Works. Anticancer Agents Med Chem 2020; 19:1786-1795. [PMID: 30827264 DOI: 10.2174/1871520619666190227171716] [Citation(s) in RCA: 42] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2018] [Revised: 10/18/2018] [Accepted: 02/07/2019] [Indexed: 12/27/2022]
Abstract
BACKGROUND Schiff bases and their metal complexes are emerging as key classes of medicinal compounds, possessing an enormous potential of biological activities like anticancer, anticonvulsant and antioxidant etc. The aim of this review is to examine the anticancer activity of different classes of Schiff bases and their metal complexes. METHODS Anticancer activity of the already synthesized as well as the novel Schiff bases and their metal complexes was studied using different assays such as 3- [4,5-dimethyltiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT), PI staining, Sulforhodamine, Allium cepa, Sulfo- Rhodamine-B-stain(SRB), viability and potato disc against various human and animal cancer cell lines. RESULTS The test results indicated significant differences in anticancer activity between subclasses of Schiff base compounds as well as between the Schiff base ligands and their metal complexes. Quinazolines showed a very high activity against HepG2 and MCF-7 cell lines. Pyrazole-naphthalene derivatives exhibited high activity against numerous carcinoma cells while [Ni(HL1)2(OAc)2] showed the highest. Azosal and its tin(IV) complexes displayed high activity against U-1242 MG and excellent activity against HCT-116 cell lines. 2-thiouracil sulfonamides displayed high activity against MCF7, CaCo-2 carcinoma cells. Vitamin-B6 and its oxovanadium complex showed good activity against MCF-7, 3T3 and cervical cancer HeLa cancer cell lines in the presence of visible light. Indoles displayed high activity against AMJ13. Porphyrines derivatives exhibited good activity while its binuclear(Y and K) complexes displayed high activity against several carcinoma cells. Chitosan complexes of [Pd(II) and Pt(II)] showed a very high anticancer activity against MCF-7 carcinoma cell. CONCLUSION Schiff bases possess a high potential to inhibit carcinoma cells which enhanced with complexation, but the mechanism of their antitumor activity is still doubt.
Collapse
Affiliation(s)
- Kirubel T Tadele
- Chemistry Department, Natural Science College, Jimma University, Jimma, Ethiopia
| | - Tilahun W Tsega
- Chemistry Department, Natural Science College, Jimma University, Jimma, Ethiopia
| |
Collapse
|
9
|
Wang Y, Wang Z, Kuang H, Zhang Y, Gu W, Zhu Y, Wang S. Synthesis and antitumor activity of 2-isocamphanyl thiosemicarbazone derivatives via ROS-enhanced mitochondrial damage. Chem Biol Drug Des 2019; 94:1281-1291. [PMID: 30689273 DOI: 10.1111/cbdd.13492] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2018] [Revised: 12/14/2018] [Accepted: 01/19/2019] [Indexed: 01/05/2023]
Abstract
A series of novel 2-isocamphanyl thiosemicarbazone derivatives were synthesized and characterized by 1 H NMR, 13 C NMR, and HRMS. In in vitro anticancer activity, most derivatives showed considerable cytotoxic activity against four cancer cell lines (RPMI-8226, A549, MDA-MB-231, and HepG2 cancer cells) and showed low toxicity against human gastric mucosal cells (GES-1). Among them, compound 4h exhibited excellent antitumor activity against the tested cancer cells with IC50 values of 0.4, 1.1, 1.6, and 1.7 μM for MDA-MB-231, RPMI-8226, A549, and HepG2, respectively. Further, mechanism studies indicated that compound 4h induced apoptosis in MDA-MB-231 cells through enhancing reactive oxygen species levels, inducing mitochondrial membrane potential decrease, and influencing the expression of Bax, Bcl-2, caspase-3, and caspase-9.
Collapse
Affiliation(s)
- Yunyun Wang
- College of Chemical Engineering, Nanjing Forestry University, Nanjing, China
| | - Zhonglong Wang
- College of Chemical Engineering, Nanjing Forestry University, Nanjing, China
| | - Hongbo Kuang
- College of Chemical Engineering, Nanjing Forestry University, Nanjing, China
| | - Yan Zhang
- College of Chemical Engineering, Nanjing Forestry University, Nanjing, China
| | - Wen Gu
- College of Chemical Engineering, Nanjing Forestry University, Nanjing, China.,Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Nanjing Forestry University, Nanjing, China
| | - Yongqiang Zhu
- Jiangsu Chia Tai Fenghai Pharmaceutical Co. Ltd, Nanjing, China
| | - Shifa Wang
- College of Chemical Engineering, Nanjing Forestry University, Nanjing, China.,Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Nanjing Forestry University, Nanjing, China
| |
Collapse
|
10
|
Synthesis, X-Ray Crystal Structures, and Preliminary Antiproliferative Activities of New s-Triazine-hydroxybenzylidene Hydrazone Derivatives. J CHEM-NY 2019. [DOI: 10.1155/2019/9403908] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
We herein report a new small library of Schiff-base compounds that encompasses s-triazine and (2 or 4)-hydroxylbenzylidene derivatives. These compounds were synthesized through a hydrazone linkage connecting both the s-triazine and hydroxybenzylidene derivatives. The synthetic strategy adopted allowed the synthesis of the target compounds with excellent yields and purities as observed from their NMR (1H and 13C) and elemental analysis. Furthermore, 4f, 5b, and 5f were further confirmed by X-ray single crystal diffraction technique. The preliminary antiproliferative activities for the synthesized compounds were tested against two different cancer cell lines including breast cancer (MCF-7) and colon cancer (HCT-116). From the eighteen compounds, which have been examined, only two derivatives having piperidine moiety showed more selectivity against the two cell lines MCF-7 and HCT-116, while the others showed very weak activity. The position of the hydroxyl group in the benzylidine ring and the substituent on the s-triazine moiety has great effect on the activity of the prepared compounds. The IC50 values for the two derivatives 4a and 5a evaluated against breast cancer cells, very close to those for the chemotherapeutic drug cisplatin, are 27 µM (13.3 µg/mL), 17 µM (8.4 µg/mL), and 20 µM (6 µg/mL) for 4a, 5a, and cisplatin, respectively. These results propose the preliminary antiproliferative activity of these two derivatives may deserve further consideration for development of new derivatives as potent anticancer agents.
Collapse
|